| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |